The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

3D visualization of vascular lesions and the role of versican in pulmonary arterial hypertension

Portrait of Christian Westöö

Pulmonary hypertension, high blood pressure in the lung, is a devastating condition where no curative treatment is available. Christian Westöö, PhD student in Karin Tran Lundmark's research team, has used synchrotron-based micro-CT as a tool for increased understanding of disease distribution in 3D space, in human tissue from patients with pulmonary arterial hypertension.

Christian Westöö is currently doing his final preparations before his dissertation the 28th of October. His thesis work demonstrates the value of synchrotron-based phase-contrast micro-CT  for 3D imaging of paraffin-embedded pulmonary tissue at a micrometer level.

Synchrotron-based phase-contrast micro-CT revealed four types of plexiform lesions in pulmonary arterial hypertension (PAH), leading to a novel classification. The imaging also confirmed patent pulmonary to systemic shunts within some types of plexiform lesions.

The role of versican (a proteoglycan) in pulmonary hypertension was also studied. Results showed significant enzymatic turnover in human PAH lesions leading to a plasma analysis where a fragment of versican was found to be significantly elevated in patients: a possible future biomarker. No ameliorating effect of versican knockdown in a murine disease model was found, perhaps because of lack of occlusive lesion formation in this model. Synchrotron-based phase-contrast micro-CT imaging revealed human-like occlusive vascular lesion formation in mice exposed to house dust mite, indicating this model to be more suitable for studies of the role of versican in vivo. 

2022-10-28 | Dissertation

Place: To be announced
Time: 09:00
Title: 3D visualization of vascular lesions and the role of versican in pulmonary arterial
Opponent: Professor D. Jonigk, Aachen University Hospital
Supervisor: Karin Tran Lundmark